Page 5 - Pfizer Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer CEO says third dose ‘likely’ needed within 1 year: report Studies underway to determine if third dose will be needed Tags:  FILE - In this Feb. 19, 2021, file photo President Joe Biden walks by freezers used to hold the Pfizer COVID-19 vaccine as he tours a Pfizer manufacturing site with Albert Bourla, Pfizer CEO, in Portage, Mich. (AP Photo/Evan Vucci, File) (Copyright 2021 The Associated Press. All rights reserved) ORLANDO, Fla. – Pfizer CEO Albert Bourla told CNBC Thursday people will most “likely” need another dose of the COVID-19 vaccine within a year of their full vacc...

Most people have minor symptoms, but immune response worth it, doctors remind

Tuesday, 16 Mar 2021 03:31 PM MYT Subscribe to our Telegram channel for the latest updates on news you need to know. MARCH 16 ― This fear-mongering Whatsapp message has been making its rounds recently by the same set of individuals and NGOs. This is the same group whom I have replied their 19 questions and debunked their baseless allegations on Covid vaccines. Instead of replying with facts and figures, they chose the immature and cowardly route of being personal and using gutter politics. Grow up guys! These are the same guys who insisted the MoH roll out our Ivermectin without any further...

2 shares An Israeli healthcare worker prepares a dose of the coronavirus vaccine at a Clalit Health Services clinic in Jerusalem on January 14, 2021. (Ahmad Gharabli/AFP) 1. Holding steady on the cusp of disaster: The good news in Israel is that the number of new coronavirus cases no longer appears to be rising. The bad news is that the plateau is at a horrifyingly high level. “It’s not going up, but not going down,” anchor Udi Segal told Channel 13 viewers Thursday night at the top of the nightly primetime news broadcast. “For the fourth day running: over 9,000 cases a day,” ...

Nathan Jeffay is The Times of Israel's health and science correspondent A health worker prepare a vaccination against COVID-19 at a Clalit vaccination center in Jerusalem, on December 31, 2020 (Olivier Fitoussi/Flash90) Until now, Israel’s speedy coronavirus vaccination rollout has been the source of awe, envy (and some criticism) worldwide. But with the release of preliminary data on how hundreds of thousands of people have responded to the shots, it’s also set to be the source of groundbreaking insights expected to help bolster vaccination efforts globally. Most notably, the data releas...